UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

PATient Navigator to rEduce Readmissions

Not Applicable

Completed

Conditions: Heart Failure
Pneumonia
Chronic Obstructive Pulmonary Disease
Sickle Cell Disease
Myocardial Infarction

Interventions: Behavioral: Hospital usual care
Behavioral: Navigator intervention
Behavioral: Peer-led telephone support line

First Posted Date: 2014-04-15

Last Posted Date: 2019-02-15

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 1029

Registration Number: NCT02114515

Locations: 🇺🇸
University of Illinois Hospital, Chicago, Illinois, United States

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Behavioral: Written education material (basic)
Behavioral: Additional education material
Behavioral: PELICAN-Reactive
Behavioral: PELICAN-Proactive

First Posted Date: 2014-03-28

Last Posted Date: 2018-08-06

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 444

Registration Number: NCT02098369

Locations: 🇺🇸
Apria Healthcare, Lake Forest, California, United States
🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸
University of Illinois Hospital, Chicago, Illinois, United States

and more 3 locations

Family Nutrition Physical Activity Tool Use During Well Child Visits

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Usual Care
Behavioral: FNPA tool

First Posted Date: 2014-02-20

Last Posted Date: 2016-03-23

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 430

Registration Number: NCT02067728

Locations: 🇺🇸
UnityPointHealth Methodist in Peoria, Peoria, Illinois, United States

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

Phase 4

Terminated

Conditions: Proteinuria
Transplant Glomerulopathy

Interventions: Drug: Acthar

First Posted Date: 2014-02-07

Last Posted Date: 2020-09-04

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 2

Registration Number: NCT02057523

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Phase 1

Completed

Conditions: Multiple Myeloma, Relapsed
Multiple Myeloma, Refractory to Standard Treatment

Interventions: Radiation: Total Marrow Irradiation
Drug: Melphalan
Drug: Filgrastim (G-CSF)
Procedure: Autologous transplant

First Posted Date: 2014-01-23

Last Posted Date: 2024-11-13

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 12

Registration Number: NCT02043847

Locations: 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

Phase 1

Terminated

Conditions: Multiple Myeloma

Interventions: Radiation: Total Marrow Irradiation
Procedure: Autologous Transplant
Drug: Melphalan
Drug: Filgrastim (G-CSF)

First Posted Date: 2014-01-23

Last Posted Date: 2019-10-14

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 3

Registration Number: NCT02043860

Locations: 🇺🇸
UIC Cancer Center, Chicago, Illinois, United States

Feeding and Transition to Home for Preterms at Social Risk

Not Applicable

Completed

Conditions: Premature Birth

Interventions: Behavioral: H-HOPE
Other: Attention Control

First Posted Date: 2014-01-22

Last Posted Date: 2021-04-13

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 198

Registration Number: NCT02041923

Locations: 🇺🇸
Mount Sinai Medical Center, Chicago, Illinois, United States
🇺🇸
Mercy Hospital and Medical Center, Chicago, Illinois, United States

Computerized PAINRelieveIt Protocol for Cancer Pain Control in Hospice

Not Applicable

Conditions: Cancer
Pain

Interventions: Behavioral: PAINReportIt
Behavioral: PAINConsultN
Behavioral: PAINUCope

First Posted Date: 2014-01-01

Last Posted Date: 2015-05-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 380

Registration Number: NCT02026115

Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients

Completed

Conditions: CKD Stage 3/4

Interventions: Drug: Vitamin D 2mg daily for 2 weeks oral paricalcitol
Drug: Placebo

First Posted Date: 2013-12-23

Last Posted Date: 2020-08-17

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 8

Registration Number: NCT02018133

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Device: Portable monitoring
Other: Polysomnography
Device: Home portable monitoring
Device: Laboratory portable monitoring

First Posted Date: 2013-11-28

Last Posted Date: 2024-05-29

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 75

Registration Number: NCT01997723

Locations: 🇺🇸
Sleep Science Center, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy